Works matching DE "INSULIN secretagogues"


Results: 88
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12

    Association between residual islet beta‐cell function and achieving the target of time in range in inpatients with type 2 diabetes undergoing antidiabetic treatment: An observation study.

    Published in:
    Diabetes, Obesity & Metabolism, 2023, v. 25, n. 6, p. 1714, doi. 10.1111/dom.15026
    By:
    • Xia, Zhang;
    • You, Wenjun;
    • Li, Yuhao;
    • Li, Feng;
    • Hao, Shuai;
    • Sun, Yihan;
    • Li, Na;
    • Lin, Lu;
    • Dou, Jingtao;
    • Su, Xin;
    • Zhai, Qi;
    • Zuo, Yingting;
    • Zhang, Yibo;
    • Gaisano, Herbert Y.;
    • Zheng, Deqiang;
    • He, Yan;
    • Jiang, Jiajia
    Publication type:
    Article
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29

    Diabetic Osteodystrophy.

    Published in:
    Endocrinology Research & Practice, 2024, v. 28, n. 3, p. 175, doi. 10.5152/erp.2024.24463
    By:
    • Eren, Mehmet Ali;
    • Gül, Özen Öz
    Publication type:
    Article
    31
    32
    33
    34
    35

    Effect of Time-Restricted Eating on Weight Loss in Adults With Type 2 Diabetes: A Randomized Clinical Trial.

    Published in:
    JAMA Network Open, 2023, v. 6, n. 10, p. e2339337, doi. 10.1001/jamanetworkopen.2023.39337
    By:
    • Pavlou, Vasiliki;
    • Cienfuegos, Sofia;
    • Lin, Shuhao;
    • Ezpeleta, Mark;
    • Ready, Kathleen;
    • Corapi, Sarah;
    • Wu, Jackie;
    • Lopez, Jason;
    • Gabel, Kelsey;
    • Tussing-Humphreys, Lisa;
    • Oddo, Vanessa M.;
    • Alexandria, Shaina J.;
    • Sanchez, Julienne;
    • Unterman, Terry;
    • Chow, Lisa S.;
    • Vidmar, Alaina P.;
    • Varady, Krista A.
    Publication type:
    Article
    36
    37
    38

    Clinical and Laboratory Characteristics of MODY Cases, Genetic Mutation Spectrum and Phenotype-genotype Relationship.

    Published in:
    Journal of Clinical Research in Pediatric Endocrinology, 2024, v. 16, n. 3, p. 297, doi. 10.4274/jcrpe.galenos.2024.2023-10-16
    By:
    • Özsu, Elif;
    • Çetinkaya, Semra;
    • Bolu, Semih;
    • Hatipoğlu, Nihal;
    • Erdeve, Şenay Savaş;
    • Evliyaoğlu, Olcay;
    • Baş, Firdevs;
    • Çayır, Atilla;
    • Dündar, İsmail;
    • Akbaş, Emine Demet;
    • Uçaktürk, Seyid Ahmet;
    • Berberoğlu, Merih;
    • Şıklar, Zeynep;
    • Özalkak, Şervan;
    • Şahin, Nursel Muratoğlu;
    • Keskin, Melikşah;
    • Şiraz, Ülkü Gül;
    • Turan, Hande;
    • Öztürk, Ayşe Pınar;
    • Mengen, Eda
    Publication type:
    Article
    39
    40
    41
    42
    43
    44
    45
    46

    Causes of In-Hospital Death and Pharmaceutical Associations with Age of Death during a 10-Year Period (2011–2020) in Individuals with and without Diabetes at a Japanese Community General Hospital.

    Published in:
    Journal of Clinical Medicine, 2024, v. 13, n. 5, p. 1283, doi. 10.3390/jcm13051283
    By:
    • Hosoki, Minae;
    • Hori, Taiki;
    • Kaneko, Yousuke;
    • Mori, Kensuke;
    • Yasui, Saya;
    • Tsuji, Seijiro;
    • Yamagami, Hiroki;
    • Kawata, Saki;
    • Hara, Tomoyo;
    • Masuda, Shiho;
    • Mitsui, Yukari;
    • Kurahashi, Kiyoe;
    • Harada, Takeshi;
    • Nakamura, Shingen;
    • Otoda, Toshiki;
    • Yuasa, Tomoyuki;
    • Kuroda, Akio;
    • Endo, Itsuro;
    • Matsuhisa, Munehide;
    • Aihara, Ken-ichi
    Publication type:
    Article
    47

    Clinical Effectiveness and Safety of Once-Weekly GLP-1 Receptor Agonist Dulaglutide as Add-On to Metformin or Metformin Plus Insulin Secretagogues in Obesity and Type 2 Diabetes.

    Published in:
    Journal of Clinical Medicine, 2021, v. 10, n. 5, p. 985, doi. 10.3390/jcm10050985
    By:
    • Mirabelli, Maria;
    • Chiefari, Eusebio;
    • Tocci, Vera;
    • Caroleo, Patrizia;
    • Giuliano, Stefania;
    • Greco, Emanuela;
    • Luque, Raul Miguel;
    • Puccio, Luigi;
    • Foti, Daniela Patrizia;
    • Aversa, Antonio;
    • Brunetti, Antonio;
    • Huang, Paul L.
    Publication type:
    Article
    49
    50